Allergy Therapeutics PLC
09 January 2006
Allergy Therapeutics plc ("the Company")
The Company received notification on 6 January 2006 that Fidelity International
Limited ("FIL") and its direct and indirect subsidiaries, including Fidelity
Investment Services Ltd ("FISL"), Fidelity Gestion (FIGEST), Fidelity
Investments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments Management
(Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") and Fidelity
Investments International (FII), investment managers for various non-US
investment companies and institutional clients, are together interested in a
total of 6,862,044 ordinary shares in the Company, representing approximately
10.90 per cent. of the Company's issued share capital.
This shareholding is registered as follows:
Shares held Management Nominee/Registered Name
Company
1,231,500 FPM Northern Trust London
484,300 FPM Mellon Bank
478,800 FPM JP Morgan
438,062 FPM Bank of New York Brussels
381,484 FPM State Str Bk and TR Co LDDN
232,200 FPM Bankers Trust
121,100 FPM Midland Securities Services
78,700 FPM Clydesdale Bank plc
2,958,398 FISL JP Morgan
330,400 FIL Brown Bros Harrimn Ltd Lux
118,700 FIL Bank of New York Brussels
8,400 FIL JP Morgan
6,862,044 Total holding
This notifiable interest also comprises the notifiable interest of Mr Edward C.
Johnson III, a principal shareholder of Fidelity International Limited, and
interests held on behalf of authorised unit trust schemes in the United Kingdom.
This information is provided by RNS
The company news service from the London Stock Exchange HOLUKOVRNRRARAR
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.